To explore the clinical significance of CCL2, we classified CCL2 expression into low expression group and high expression group of 677 cases of NSCLC tissues based on the TCGA database (https://portal.gdc.cancer.gov). This evidence concerns the gene CCL2 and non-small cell lung carcinoma.